Most cancer drugs approved by EMA show little benefit: study
admin 5th October 2017 Uncategorised 0Only 35% of approved medicines between 2009-13 showed significant survival benefit at approval
More: Most cancer drugs approved by EMA show little benefit: study
Source: News